| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | — |
| R&D Expense | $13.3M | +41.8% |
| SG&A Expense | $4.3M | +4.1% |
| Interest Expense | $4.1M | — |
| Pre-tax Income | $21.7M | -25.9% |
| Income Tax | $4K | — |
| Net Income | -$21.7M | +26.0% |
| EPS (Basic) | -$1.21 | +51.0% |
| EPS (Diluted) | -$1.21 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $12.7M | +1823.6% |
| Current Assets | $19.6M | +1553.5% |
| Total Assets | $20.0M | +959.2% |
| Current Liabilities | $5.3M | +185.0% |
| Total Liabilities | $5.4M | +162.2% |
| Stockholders' Equity | $14.6M | +8998.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$14.7M | -23.2% |
| Capital Expenditures | $58K | -26.9% |
| Investing Cash Flow | -$6.1M | -366.7% |
| Financing Cash Flow | $29.8M | +1019.2% |
| Free Cash Flow | -$14.8M | -22.9% |